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The treatment of municipal wastewater in the Arctic is challenging due to a variety of financial, oper-
ational, climatic and technical issues. To better understand the efficacy of current wastewater treatment
in this region and the hazard posed to receiving waters, we assessed the occurrence of nutrients and
contaminants (i.e., pharmaceuticals, antibiotic resistance genes) as they moved through a lagoon-based
treatment system in Cambridge Bay, Nunavut, Canada. Wastewater treatment in this community is
performed by the use of a lagoon-tundra wetland system that is discharged into the marine environment
and is representative of current common practices throughout the region. In 2014, samples were
collected before and during lagoon discharge from two locations in the main lagoon, one location
downstream from the lagoon effluent and three locations offshore. Grab samples were collected to
measure nutrients (e.g., total nitrogen and phosphorus) and the presence of antibiotic resistance gene-
bearing microbes, and Polar Organic Chemical Integrative Samplers (POCIS) were deployed to collect
passively organic contaminants in all locations. A total of six pharmaceuticals were detected from a
screen of twenty-eight analytes during the study: atenolol, carbamazepine, clarithromycin, metoprolol,
sulfamethoxazole and trimethoprim. The greatest concentrations of nutrients, antibiotic resistance genes
(ARGs), and pharmaceuticals were found in sampling locations within the treatment lagoon. Offshore of
the release point, we observed limited to no detection of pharmaceuticals and ARGs, but no change in
total nitrogen and phosphorus from pre-release. We conclude that the current concentrations of
monitored pharmaceuticals do not pose a significant hazard at this time to aquatic organisms in Cam-
bridge Bay.
© 2016 Elsevier Ltd. All rights reserved.1. Introduction
Organic contaminants in wastewater effluents, including phar-
maceuticals, are released to aquatic ecosystems and have been
found to pose a hazard under certain conditions to receiving wa-
ters; this poses a challenge for current wastewater treatment
practices in many regions (Fent et al., 2006). Many pharmaceuticalse by Dr. Chen Da.
Environment, Department of
of Chemistry, The University
C.S. Wong).such as anti-inflammatory drugs, antidepressants and antibiotics
are not fully eliminated in the body, and thus enter the sewage
system as both parent compounds and their metabolites (Vasskog
et al., 2009). Many current wastewater treatment systems are not
specifically designed to eliminate organic contaminants and, as a
consequence, many of these pollutants are able to persist through
wastewater treatment processes (Gunnarsdottir et al., 2013). In
addition, monitoring actions for most micropollutants have not
been well established in most wastewater treatment facilities
(Bolong et al., 2009). Another concern is the presence of organisms
that carry antibiotic resistance genes (ARGs), which can threaten
public health (Rowan, 2011). Antibiotic resistance genes in the
environment are often present due to human and veterinary use of
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Graham et al., 2011). Nutrient enrichment has also been a poten-
tial hazard to the aquatic environment with increasing eutrophi-
cation in freshwater and enclosed marine systems downstream of
areas of urbanization (Smith, 2003). While the releases of effluents
have been characterized for many countries and regions of the
world (Luo et al., 2014), little to no work has been performed to
quantify organic micropollutants and their risk in polar regions
because of the difficulties associated with travel logistics and
sample holding limitations. Therefore, collecting sample replicates
and comprehensive datasets suitable for statistical analysis is
highly constrained in these regions. As a consequence, there is a
lack of understanding of the environmental risks, system perfor-
mance, and treatment processes associated with polar treatment
systems (Chouinard et al., 2014).
Some studies have been performed in Arctic environments for
the screening of pharmaceuticals and personal care products in
wastewaters. For example, Weigel et al. (2004) characterized
selected pharmaceuticals in the sewage of Tromsø, Norway and in
the seawater of Tromsø-sound, receiving these wastewaters. These
chemicals included ibuprofen and its metabolites, the insect re-
pellent N,N-diethyl-3-toluamide, as well as caffeine, included as a
tracer for domestic sewage. Emnet et al. (2015) studied the occur-
rence of personal care products in two Antarctic research stations,
detecting six analytes in treated wastewaters, including the UV
filters 4-methyl-bezylidene camphor, 2-hydroxy-4-
methoxybenzophenone and 2,4-dihydroxybenzophenone, the
plastic monomer 2,2-bis(4-hydroxyphenyl)-propane, the steroid
hormone estrone and the antimicrobial triclosan. These com-
pounds were detected at concentrations comparable to those re-
ported for international coastal waters next to significantly greater
human populations (Balmer et al., 2005).
In many regions of the Arctic, the release of sewage with min-
imum or no treatment can have consequences for the receiving
environment, given the high vulnerability of the Arctic ecosystem
to environmental contaminants (Gunnarsdottir et al., 2013).
Kallenborn et al. (2008) reported that pharmaceutical residues are
degraded slower in Arctic environments compared to release sce-
narios in lower latitudes. In their study a set of nine different an-
tidepressants and their transformation products were analyzed in
receiving seawater from two locations in Norway, one of them in a
northern region. Increased environmental stability of these com-
pounds was detected in the Arctic environment compared to the
temperate location. The removal of pharmaceutical residues by
photodegradation is limited during the Arctic polar night and the
intensity of sunlight (even continuously during periods of midnight
sun) at other times of the year is less intense than that of more
temperate regions. Both limited photodegradation during the
winter and the cold Arctic climate can slow down the degradation
rate of pharmaceutical residues in the environment
(Schwarzenbach et al., 2003).
Arctic communities frequently experience several challenges in
order to perform adequate treatment of their wastewaters. Char-
acteristics such as geographical remoteness, adverse weather and
lack of basic services are common in many communities and make
wastewater treatment, whenever possible, a difficult task (Yates
et al., 2012). The scarcity of accredited laboratories for compli-
ance testing and the necessity for trained personnel to manage
wastewater facilities are challenges that need to be overcome by
these communities on a daily basis. Also, subsistence fishing is a
significant industry in many Arctic coastal regions, for which
pollutant contamination of marine species is a major concern.
Exposure to micropollutants and their uptake in the food web can
have hazardous effects on human health and the environment
through bioaccumulation and biomagnification of chemicals(Gunnarsdottir et al., 2013). With regards to human health, the
Canada Health Actmandates that themajority of health services are
publicly funded and available for all Canadians, with administration
at provincial and territorial levels. However, differences do exist in
the health status of aboriginal and non-aboriginal Canadians. For
example, First Nations populations experience greater rates of
mental illness, suicide, diabetes, asthma, cardiovascular disease,
tuberculosis, hepatitis, syphilis and HIV/AIDS than non-aboriginal
populations (Romain, 2013). This can influence the amount of
pharmaceuticals that are needed to treat these diseases in Northern
Canadian communities.
To begin to address the need for knowledge about wastewater
contaminants exposure in the Arctic, it is needed to quantify the
types and quantities of nutrients and micropollutants in lagoon
discharge effluents and receiving waters. Such an effort would
allow a partial understanding of the possible hazards associated
with wastewater discharges into receiving environments. In this
study, we examined the efficacy of wastewater treatment under
arctic conditions, by assessing the occurrence of selected waste-
water contaminants attenuation and release from a wastewater
treatment facility in Cambridge Bay, Nunavut, Canada. Our objec-
tives were: first, to obtain recent exposure data for the wastewater
contaminants in Cambridge Bay, regarding to the concentrations of
nutrients (total nitrogen and phosphorus), ARGs and pharmaceu-
ticals; and second, to provide a baseline of the current state of
wastewater treatment in Cambridge Bay, in anticipation of the
eventual instalment, expected by 2017, of the Canadian High Arctic
Research Station (CHARS), a scientific facility for Arctic research, as
well for expanding populations in the Arctic in general. Of partic-
ular interest was the exposure data at the water intake point that
CHARS will eventually use for research purposes. We were also
interested on assessing the facility for evidence of any leaky sewage
infrastructures, specifically at Finger Bay. We hypothesize that the
wastewater contaminants in Cambridge Bay do not pose a signifi-
cant risk at this time to the marine environment, and that the
lagoon-wetland system in this community has the ability to
perform partial attenuation on nutrients, pharmaceuticals and
antibiotic resistance genes.
2. Materials and methods
2.1. Study location
Cambridge Bay is located in the territory of Nunavut in the Ca-
nadian Arctic. It has a population of approximately 1400. Mean
monthly temperatures range from a dailymaximum andminimum,
respectively, of 28 C and 35 C in January to 13 C and 5 C in
July (Government of Canada, 2014). The opening of CHARS in 2017
will likely have an impact in the community in terms of increases in
population and use of water resources, including wastewater
disposal and treatment.
The wastewater system monitored at Cambridge Bay is
comprised of a wastewater lagoon, formerly a series of natural
lakes, that performs primary treatment and is discharged once a
year, during the summer, into a small hydrologically-isolated nat-
ural tundra wetland. Wastewater then is released through an open
channel into the marine environment. Municipal sewage from
household sewage tanks is regularly transported to the lagoon by
sewage trucks that perform dumping runs year-round.
2.2. Sample collection
The selection of sampling sites was done in consultation with
local municipal authorities with an overarching aim of character-
izing the composition of wastewaters and receiving waters for the
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around the study site (Fig. 1). These were: approximately 20 m
away from a new wastewater drop off point (Lagoon Input 1);
approximately 20 m away from an older drop off point (Lagoon
Input 2); at the outflow of the natural tundra wetland (Wetland);
approximately 100 m offshore of the primary discharge point
(approximately 100 m from the Wetland site) to the bay (Outfall);
at the CHARS' proposed seawater intake point (CHARS); and at a
previously used run-off discharge point culvert, currently closed,
located around 300 m west from the main discharge point (Finger
Bay). No significant rain events were registered during the sam-
pling. Pharmaceuticals were passively sampled using triplicate
POCIS (Environmental Sampling Technologies, St Joseph, MO) in the
“pharmaceutical” configuration as described by MacLeod and
Wong (2010). Sampling was performed both before and during
release of wastewater from the lagoon. Pre-release POCIS sampling
was performed from July 25 to August 8, 2014 for inland locations,
and from July 26 to August 9 for offshore locations. Wastewater
release occurred from August 28 to September 5 with POCIS sam-
pling performed from August 29 to September 8 at all locations.
Grab-sampling for nutrients (composite sample) and ARGs (tripli-
cates) was conducted on July 25 in the pre-release stage, and on
September 3 during release. Field blanks immersed in nanopure
water (18 MU-cm, Millipore, Billerica, MA) in the appropriateFig. 1. Sampling site locations at the Cambridge Bay wastewater treatment facility and receiv
line.containers were opened during sampling to determine the extent
of contamination. Samples were kept on ice within 24 h after the
sampling for transport to the local laboratory, and shipped on ice
back to Winnipeg for processing. Samples for nutrients were
collected in 50 mL falcon tubes. Personnel wore gloves disinfected
with 70% isopropanol, while handling ARG samples, which were
collected in autoclaved 500 mL polyethylene bottles pre-release
(July 25) and during release (September 3) from all sampling lo-
cations. Bottles were rinsed three times with sample water before
being filled to the top with no headspace. Field blanks filled with
nanopure water (18 MU-cm, Millipore, Billerica, MA) in the
appropriate containers were opened during sampling to determine
the extent of contamination. Samples were kept on ice within 24 h
after the sampling for transport to the laboratory, where ARGs
samples were filtered in a sterile environment. These filters were
kept at 20 C until shipment to the University of Strathclyde for
ARG analysis.
2.3. Determination of pharmaceuticals and nutrients
We followed the methods of Carlson et al. (2013), for the anal-
ysis of pharmaceuticals. Ultra high-performance liquid
chromatography-tandemmass spectrometry (UHPLC/MS/MS) with
isotope dilution was used to quantify chemicals of interest in watering waters. Wastewater path from the lagoon to the bay is shown by means of a dotted
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commonly-used micropollutants frequently found in wastewaters
(Fatta-Kassinos et al., 2011), including b-blockers (e.g. metoprolol);
antidepressants (e.g. fluoxetine); anticonvulsant drugs (e.g. carba-
mazepine) and macrolide (e.g. clarithromycin) and sulfonamide
(e.g. sulfamethazine) antibiotics. Limits of quantification (LOQ) are
found in Table S1, and other quality assurance/quality control pa-
rameters details in Carlson et al. (2013). Time-weighed average
(TWA) concentrations were calculated by dividing the determined
mass of chemical (ng) in the sampler by the sampling rate (L/d)
times the deployment time (d) for all detected micropollutants,
making use of sampling rates (Table S2) found in the literature
(MacLeod et al., 2007; Bartelt-Hunt et al., 2011). Concentrations of
nutrients (e.g. total nitrogen and total phosphorus) were deter-
mined before and during discharge following standard methods
(APHA, 2005).
2.4. Hazard assessment for detected pharmaceuticals
A hazard assessment was performed for detected compounds by
calculating hazard quotients (HQs) using standard tests and end-
points from aquatic toxicological studies, particularly for primary
producers, invertebrates and fish. Briefly, estimates for effective
concentrations (EC50) or lethal concentrations (LC50) were ob-
tained through a literature search without any assessment of study
quality. For added conservatism, we employed an uncertainty fac-
tor of 1000 to the lowest EC50 or LC50S as is typically done. The
maximum measured environmental concentration was then
divided by the lowest reported effect concentration (typically
freshwater, as marine organism tests were lacking) to obtain the
hazard quotient. Hazard quotients greater than 1 were considered
to be of concernwhile those compounds with HQ values less than 1
were considered less likely to pose a concern.
2.5. Determination of antibiotic resistance genes
Antibiotic resistance genes were quantified from cells harvested
on filters following cell disruption (FastPrep, MP Biomedicals; 2
cycles at 30 s each at 6.0 setting) and DNA purification (MoBio
PowerClean Soil DNA kit; Cambio, Cambridge, UK), similar to
methods previously used (Anderson et al., 2015; Cardinal et al.,
2014). A multiplex assay was used to target an array of tetracy-
cline resistant genes (Ng et al., 2001), sulfonamide resistant genes
(Pei et al., 2006) and 16S-rRNAwas quantified as a measure of ‘total
bacteria’. Quantitative PCR was conducted using a BioRad iQ cycler
(BioRad, Hercules, CA) using ssoFast EvaGreen reagents (BioRad)
and 500 nM primer concentrations. All samples were diluted 1:100
with molecular grade water, as reactions were predetermined to be
most efficient at those sample concentrations; standards and post-
analytical melting curves were generated (Smith et al., 2004) to
verify PCR reactions quality and quantify results.
2.6. Statistical analysis
Changes in concentrations of pharmaceuticals, as well as
abundance of ARGs, from before and during release were assessed
using a Student's paired t-test. Concentration data are presented as
mean ± standard deviation (St. Dev.) unless otherwise indicated.
Differences were considered significant at p < 0.05.
3. Results and discussion
3.1. Nutrients
Nutrient samples had to be combined in order to measureconcentrations at many sites, particularly those offshore given very
low levels there (Table 1). Thus, only a single measurement was
made per site per sampling time, so our discussion of changes in
concentrations is qualitative in nature.
Total nitrogen showed values over 10 mg/L for the lagoon sites
both before and during release measurements. Concentrations at
Lagoon Input 1 and Lagoon Input 2 showed similar levels at both
times, with the Wetland site having an increase in concentration
after the wastewater discharge started. There was no apparent
reduction in the concentration of nitrogen in the lagoon or the
wetland in the two time periods. Locations offshore (e.g. Outfall,
CHARS) showed much lower concentrations. Total phosphorus
levels were approximately 2 mg/L for both lagoon sites prior to
wastewater discharge. After the discharge commenced, phos-
phorus levels in the wetland were elevated to approximately 2 mg/
L as well, with no apparent reduction from additional wetland
treatment. Phosphorus levels appear to be greater and nitrogen
values appear to be lesser than themaximumvalues recommended
for Canadian provinces such as Manitoba, in which limits of 1 mg/L
total phosphorus and 15 mg/L total nitrogen exist for wastewater
effluents discharged to awater body (ManitobaWater Stewardship,
2011). However, policies for communities in the far north have not
yet been defined and a joint governmental commission has been
assigned to define them by 2019 (CCME, 2014). Considerable dilu-
tion was observed for all locations offshore (e.g. Outfall, CHARS),
which was consistent with the nitrogen measurements. Finger Bay
showed reduced levels for both total nitrogen and phosphorus,
which suggests that there is little possibility of runoff from the
main lagoon to this location contrary to prior speculations that this
was a route of contamination from the lagoon to the bay. The levels
of phosphorus we measured pre-release are comparable to that in
the water column at the center of Cambridge Bay and at Dease
Strait, a waterway immediately west of Cambridge Bay
(0.01e0.04 mg/L, C. J. Mundy, unpublished data). Surface concen-
trations of phosphorus at the Outfall site are roughly twice those
levels, suggesting the possibility of localized effects of phosphorus
that are not evident at points farther away in the bay (Table 1).
While nutrient levels during release are likely locally elevated
relative to concentrations in the greater Canadian Arctic (Tremblay
et al., 2015), more work is warranted to examine to what extent
these added nutrients may influence the local ecosystem of Cam-
bridge Bay and Dease Strait.
No apparent nutrient removal was observed during discharge as
a result of lagoon-wetland treatment. As noted, statistical analysis
of nutrient concentrations was not possible. Nor canwe rule out the
possibility that nutrient concentrations may have been affected by
heterogeneous distributions within different locations of the
lagoon. That having been said, the data obtained in this study differ
from the results obtained in a previous work by Yates et al. (2012),
in which three larger lagoon-wetland systems in Nunavut (Arviat,
Whale Cove and Coral Harbour) were studied, observing reductions
up to 84e99% for NH3eN and 80e99% for total phosphorus. It is
known that the community of Arviat makes use of berms and
channels to direct wastewater flow away from the ocean and to
keep a longer residence time in the wetland (Wootton et al., 2008),
whereas in the Cambridge Bay wetland, the residence time of
wastewater is limited by the landscape topography and the scarce
available vegetation. It is yet unclear which mechanisms play the
most important role inwastewater treatment in the Arctic. Wetland
size and vegetation coverage, as well as the potential for filtration
and sedimentation of suspended solids, and adsorption of nutrients
within the soil and water column can play a significant role.
Table 1
Levels of total phosphorus and total nitrogen in the Cambridge Bay wastewater facility before and during wastewater discharge (n¼ 1). Wastewater was grab-sampled on July
25 and September 3, 2014. The limit of detection (LOD) and limit of quantification (LOQ) values for total nitrogenwere 8 mg/L and 27 mg/L, and those for total phosphorus were
0.58 mg/L and 1.85 mg/L, respectively.
Sampling site Before discharge During discharge
Total phosphorus (mg/L) Total nitrogen (mg/L) Total phosphorus (mg/L) Total nitrogen (mg/L)
Lagoon Input 1 2.4 12.6 2.8 12.0
Lagoon Input 2 2.4 16.6 2.8 13.5
Wetland 0.7 0.4 2.5 13.3
Outfall 0.01 0.3 0.07 0.4
Finger Bay 0.01 0.3 0.03 0.3
CHARS 0.02 0.4 0.03 0.3
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Of the screened twenty-eight organic micropollutants, only six
pharmaceuticals were detected above their LOQ at any of the lo-
cations. These were atenolol, clarithromycin, metoprolol, sulfa-
methoxazole, trimethoprim and carbamazepine, detected at least
once at ng/L levels (Fig. 2). For the detected pharmaceuticals, theFig. 2. Mean time-weighted-average (TWA) levels of pharmaceuticals in Cambridge Bay was
depict the standard deviation on each case. Differences are significant for p < 0.05 and were
Integrative Samplers from July 25 to August 8, from July 26 to August 9 and from August 2greatest concentrations were measured at the Lagoon Input 1 and 2
sites, although some differences in concentration could be seen
between both of the dumping sites. Most locations offshore expe-
rienced considerable dilutionwith seawater, which was reflected in
significantly lower concentrations for all of the passively sampled
contaminants at Outfall, CHARS and Finger Bay. Although POCIS
deployment times were different before and during discharge (14tewater facility, before and during the wastewater discharge process (n ¼ 3). Error bars
assessed using paired t-tests. Wastewater was collected using Polar Organic Chemical
9 to September 8, 2014. ND: below limit of detection (LOD). DNQ: did not quantify.
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reached within six days (Vermeirssen et al., 2012).
The greatest concentration of atenolol was 97 ng/L (Lagoon
Input 1). Detected levels were significantly different (p < 0.05)
between Lagoon Input 1 and Lagoon Input 2 sites both before and
during the discharge. There was a significant reduction of 45%
observed between Lagoon Input 2 and Wetland (p < 0.05) during
the wastewater release, and heavy dilution at locations offshore,
with most sites observed to be at non-detectable levels. These re-
sults suggest processes within the wetland (e.g. sorption to plants,
microbial degradation) may reduce concentrations of atenolol un-
der Arctic conditions. A more efficient removal of atenolol has been
observed in more southern locations in Canada, with removal rates
up to 98% for example within a sewage lagoon in Dunnottar,
Manitoba under temperate conditions (Anderson et al., 2015).
Concentrations of carbamazepine were generally below 100 ng/
L in both lagoon sites, with greater concentrations reported in the
Wetland site both before and during discharge. No apparent
removal was observed as a result of wastewater passage through
the treatment wetland (p < 0.05). Offshore locations showed levels
below LOQ. Persistence of carbamazepine during the Arctic winter
was observed, with a concentration of 116 ng/L in the hydrologi-
cally isolated wetland prior to discharge. While no measurements
of pharmaceuticals occurred during the winter, we note that this
shallow wetland system and the offshore locations are essentially
frozen over completely during the winter. This would presumably
result in no chemical removal, either by microbial activity or pho-
todegradation (i.e., ice cover would block light penetration) until
summer melt.
The greatest concentration of sulfamethoxazole was 274 ng/L;
this was detected at the Lagoon Input 2 site during wastewater
discharge. Concentrations between lagoon sites were significantly
different both before and during discharge (p < 0.05), with some
attenuation observed after wetland treatment, reaching 151 ng/L
(45% removal, p < 0.05). Levels offshore were non-detectable both
before and during discharge. Unlike this study, Conkle et al. (2008)
noted over 90% removal of sulfonamides on a temperate waste-
water facility, however, the differences may have been as a result of
significantly greater temperatures and a 27-day retention period
compared to a drastically colder weather and shorter retention
time at Cambridge Bay facility of 1e2 days.
Trimethoprim was detected in concentrations under 30 ng/L at
the lagoon and wetland sites. During wastewater release, the
wetland concentration was 9.8 ng/L after significant attenuation
(p < 0.05) occurred between the lagoon and the wetland. Finally,
clarithromycin and metoprolol were detected at both of the lagoon
sites and also in the wetland at levels below LOQ. At the offshore
sites, both compounds were non-detectable, which is consistent
with what was observed for all contaminants studied.
The presence or absence of specific pharmaceuticals depends
partially on the residence time within sewage holding tanks, prior
to entry into sewage lagoons. While photodegradation is unable to
occur in septic tanks, other degradative processes like anaerobic
microbial-mediated biotransformation could occur. Consequently,Table 2
Comparison of concentrations of target pharmaceutical compounds in treated wastewa
detectable). Lac la Biche data from MacLeod and Wong (2010), Dunnottar data from And
this study. Populations are shown underneath the name of each location for comparison
Location Atenolol (ng/L) Carbamazepine
Lac la Biche, AB (8,402) ND - 100 50e300
Dunnottar, MB (692) ND - 856.5 20.1e426.1
Grand Marais, MB (252) ND 85e500
Cambridge Bay, NU (1,400) ND - 97.4 1.2e428the most labile compounds were likely partially degraded to an
unknown extent. Sorption of pharmaceuticals to septic tank par-
ticulates may also occur. Phototransformation and biotransforma-
tion are typically the most important processes for degrading
organicmicropollutants in effluent-receivingwaters. Consequently,
optimizing conditions for these processes (e.g. by using extended
periods of treatment in sewage lagoons) can mitigate environ-
mental exposure to biologically active levels of these contaminants
(Ying et al., 2009).
To our knowledge, there are no reported data for pharmaceu-
ticals from wastewater systems from Northern Canada. Neverthe-
less, a larger amount of information (Table 2) is available for treated
lagoon wastewaters using passive sampling of more southern re-
gions in Canada, including various works done in the province of
Manitoba (Anderson et al., 2013, 2015; Carlson et al., 2013) and
Alberta (MacLeod and Wong, 2010). At Cambridge Bay, all detect-
able compounds had greatest concentrations at either the lagoon or
the wetland sites and were mostly non-detectable at locations
offshore. Atenolol, carbamazepine, sulfamethoxazole and trimeth-
oprim were detected in the Cambridge Bay facility at lower levels
compared to the data obtained at Dunnottar, Manitoba (Anderson
et al., 2015). On the other hand, atenolol, sulfamethoxazole and
trimethoprim were detected in greater levels than in the Grand
Marais wastewater treatment facility. Levels of drugs were similar
in wastewaters of Cambridge Bay and Lac la Biche, Alberta
(MacLeod and Wong, 2010).
There are several factors that likely account for the differences in
pharmaceutical levels among these locations. One factor is popu-
lation, with greater populations implying greater loadings and
impact on wastewater release. The populations served by the
treatment facilities of the southern Canadian sites (Table 2) are all
on the order of several thousand, with some seasonal variability.
For example, the Dunnottar population, a popular regional summer
resort (Anderson et al., 2015) is several times greater than that of
Cambridge Bay during the summer. However, similar per capita use
of drugs may result in similar concentrations in wastewaters
(MacLeod and Wong, 2010), which appears to be the case based on
our comparisons (Table 2). Another factor is temperature, given the
fact that colder temperatures in Nunavut can cause treatment
mechanisms such as sorption to be slower and less efficient when
compared to temperate locations, as it has been previously
observed in Norway (Kallenborn et al., 2008). Both factors are likely
in play, confounding prediction of pharmaceutical levels in
wastewaters.
3.3. Risk assessment for detected pharmaceuticals
Hazard quotients (HQs) were calculated for each organic
contaminant based upon toxicity data reported in the literature for
primary producers, invertebrates and fish (Table S3). Most com-
pounds had an HQ less than 1, ranging from values between 106
and 101. Only clarithromycin presented an HQ greater than 1 for
the alga Pseudokirchneriella subcapita, which indicates that there is
a potential for growth inhibition of algal species at concentrationsters of different Canadian lagoon wastewater systems (NA: not analyzed, ND: non-
erson et al. (2015), Grand Marais data from Anderson et al. (2013), Cambridge Bay,
.
(ng/L) Sulfamethoxazole (ng/L) Trimethoprim (ng/L)
NA 10e15
ND - 1252.5 ND - 318.5
ND-21 ND
ND - 274 ND - 25.7
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for clarithromycin was greater than 1, the concentration level used
for calculation may not be necessarily representative of what could
be found in the entire lagoon. As well, the use of a 1000-fold un-
certainty factor adds a high degree of conservatism, and there was
no apparent risk posed to receiving waters. As well, in eutrophic
environments, such as these lagoons, excess nutrients can mitigate
the effects of compounds that exhibit herbicidal activity (Baxter
et al., 2013). For the rest of the detected pharmaceuticals, we can
conclude that there is likely no significant hazard to aquatic life due
to the low concentrations at which they were detected. We did lack
Arctic and marine-specific tests that would reduce the uncertainty
and did not assess for the effect of mixtures of chemical stressors.
We do recommend the development of standard toxicity tests with
Arctic marine organisms to help address this uncertainty.3.4. Abundances and removal of ARGs
Total bacterial populations were determined by means of the
abundances of 16S rRNA genes. Their presence was greatest in the
lagoon sites in both sampling periods: before the wastewater
discharge started (108.0 genes/mL in Lagoon Input 1 and 107.8
copies/mL in Lagoon Input 2), and during wastewater discharge
(107.4 genes/mL in Lagoon Input 1 and 107.5 copies/mL in Lagoon
Input 2) (Table 3). Overall, the abundances of 16S rRNA genes were
similar (i.e., differences found were not greater than one order of
magnitude) to levels reported at more southern locations in Canada
(Anderson et al., 2015). Comparing concentrations before and
during wastewater discharge, gene abundances did not change
significantly (paired t-test, t5 ¼ 1.46, p ¼ 0.203) and their distri-
bution pattern remained similar (r ¼ 0.965, p ¼ 0.002) along the
waste stream.
Clusters of tetracycline resistance and sulfonamide-resistance
genes were analyzed and the results were summed to facilitate
assessment of resistance patterns. The greatest abundances of tetR
(sum of tetracycline resistance genes) and sulR (sum of sulfonamide
resistance genes) were found in the primary lagoon, at the two
wastewater drop-off locations, being Lagoon Input 2 the one with
the greatest response, with some attenuation through the wetland
(Table 3).
Specifically in terms of the tetracycline resistance genes, dif-
ferences from lagoon levels to offshore levels were around one
order of magnitude during discharge, with locations after the
wetland having reductions most likely due to dilution. Outfall was
the sampling spot with the lower amount of tetR genes before and
after discharge. Distribution of concentrations before and during
discharge was similar (r¼ 0.941, p¼ 0.005), but became lower after
discharge (paired t-test, t5 ¼ 3.66, p ¼ 0.015) quite possibly due to
dilution with water from the environment (e.g. existing surface
water).Table 3
Abundances of antibiotic resistance genes (log(genes/mL)) harvested from grab-samples
2014; standard deviation of sample replicates (n¼ 3) are denoted in parentheses. Relative
B ¼ sulR/16S rRNA ratio) is also shown.
Sampling site Before discharge
log total tetR log total sulR log 16S rRNA
Lagoon Input 1 4.2 (0.3) 4.7 (0.5) 8.0 (0.5)
Lagoon Input 2 4.3 (0.3) 6.0 (0.7) 7.8 (0.9)
Wetland 3.9 (0.2) 4.4 (0.3) 6.8 (0.4)
Outfall 2.9 (0.2) 2.8 (0.2) 5.4 (0.4)
Finger Bay 3.0 (0.1) 2.8 (0.2) 5.3 (0.2)
CHARS 3.7 (0.2) 3.0 (0.2) 5.2 (0.4)Sulfonamide resistance genes were more highly concentrated in
the lagoon and wetland, and before discharge declined rapidly
(2e3 orders of magnitude) following the wetland. During
discharge, gene concentrations were variable at the two drop-off
points in the lagoon, with minimum to no attenuation from the
wetland. Gene distribution patterns along the waste stream were
comparable (before-during discharge; r ¼ 0.887, p ¼ 0.019), but
unlike ‘total tet’ there were significant pairwise changes (paired t-
test, t ¼ 0.506, p ¼ 0.634) as most concentrations declined, except
at the wetland and slightly in CHARS site.
To facilitate further analysis in prevalence of bacteria
throughout the treatment process, abundances of resistance genes
were divided by the abundance of 16S rRNA genes to represent
relative gene abundances. Relative abundances of ARGs were low
(e.g. less than 2% of the total as observed in the wetland) at all lo-
cations during discharge (see Table 3), which suggests a low po-
tential for ARG-bearing bacteria to exist throughout the treatment
system. Tetracycline resistance genes remain elevated in waste-
water systems if there is a source of resistance microorganism and
tetracycline usage (Peak et al., 2007), but can decline in sunlight-
exposed systems over a relatively short period of time
(Engemann et al., 2008; Zhang et al., 2009). This suggests that
tetracycline may not have been extensively used in the Cambridge
Bay population around the times of sampling. Gene concentrations
were equivalent to wastewater lagoons with minimal tetracycline
usage by source population e.g., (Peak et al., 2007), and could
already represent near-background levels (Engemann et al., 2006;
Zhang et al., 2009), which are around 102 genes/mL (Graham
et al., 2011). Detectable sulfonamide concentrations in this study
may have been sufficient to maintain selective pressure for
antibiotic-resistant bacteria; alternatively, the presence of elevated
levels may represent residual evidence of previously higher levels
of sulfonamide usage, as gene fate tends to differ from chemical fate
(e.g. Engemann et al., 2006; Peak et al., 2007).
Wastewater systems have a variable ability to reduce antimi-
crobial resistance, given the fact that generally resistant bacteria
numbers decline in wastewater treatment as bacteria are removed.
But these patterns require further investigation, as they remain a
function of bacterial community and operating conditions
(Christgen et al., 2015). Further, no studies to date have examined
the fate of antibiotic resistant bacteria in the wastewater stream at
lower temperatures, such as in the Arctic. Well-studied coliform
bacteria, which tend to carry ARGs, persist longer in colder tem-
peratures (Ŝolic and Krstulovic, 1992); however, gene persistence at
lower temperatures could be exacerbated by slowed trans-
formation rates of pharmaceutical compounds and prolonged se-
lective pressures, reduced endonuclease activity, and lowered
predation. Further investigations are required to fully elucidate
gene fate under psychrophilic conditions.taken at the Cambridge Bay wastewater treatment facility and receiving waters in
abundance of ARGs to 16S rRNA, calculated during discharge (A¼ tetR/16S rRNA ratio,
During discharge
log total tetR log total sulR log 16S rRNA A (%) B (%)
3.8 (0.2) 4.4 (0.3) 7.4 (0.4) 0.02 0.1
4.1 (0.3) 5.6 (0.3) 7.5 (0.8) 0.03 1.3
3.8 (0.2) 5.6 (0.3) 7.3 (0.6) 0.03 2.0
2.7 (0.2) 1.8 (0.1) 6.1 (0.4) 0.04 0.01
2.7 (0.2) 2.0 (0.2) 6.3 (0.4) 0.02 0.01
3.0 (0.3) 3.3 (0.3) 6.3 (0.4) 0.05 0.1
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Our assessment of the Cambridge Bay wastewater treatment
facility allowed us to detect no apparent removal of nutrients as a
result of lagoon-wetland treatment. Reduced nutrients concentra-
tions at locations offshore occurred as a result of receiving envi-
ronment dilution. Our data suggests that some attenuation
mechanisms for pharmaceuticals exist in the treatment system,
especially in the sewage lagoon and to some extent in the natural
wetland. Distribution of the wastewater contaminants within the
lagoon sites was not homogeneous, due to the presence of two
different drop off points for sewage dumping and the topography of
the lagoon. From all of the studied pharmaceuticals, only carba-
mazepine showed some persistence during the Arctic winter.
Atenolol, sulfamethoxazole and trimethoprim had dissipated prior
to the first sampling campaign. Concentrations of detected phar-
maceuticals and nutrients were minimal in the Finger Bay location,
which suggests that there was minimal runoff of wastewater to this
point. Hazard assessment for detected pharmaceuticals shows that
current concentrations of monitored pharmaceuticals do not pose a
significant hazard at this time to aquatic organisms in Cambridge
Bay. Bacterial populations were detected in similar levels to more
southern Canadian locations, with some ARGs attenuation
observed in the lagoon-wetland system and considerable dilution
at locations offshore. Finger Bay experienced non-detectable levels
for all pharmaceuticals and very low levels of ARGs, which suggests
that this locationwas not likely experiencing any sewage leaking at
the time of this study. Overall, the CHARS scientific water supply
location showed non-detectable levels for all pharmaceuticals and
very low levels of ARGs, prior to the instalment of the facility at
Cambridge Bay. This study constitutes one of first attempts ever
made to understand the occurrence of pharmaceuticals, ARGs and
nutrients onwastewater treatment facilities in the Canadian Arctic,
as well as the removal performance of these systems under polar
conditions.
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